TR-U700702 - ulifloxacin-d8 | 1246820-95-0

<p>Ulifloxacin-d8 is a medicinal compound that has been developed as an anticancer agent. It is an analog of Ulifloxacin, which is a potent kinase inhibitor that has shown promise in the treatment of cancer. Ulifloxacin-d8 has been shown to inhibit the activity of protein kinases, which are enzymes that play a key role in regulating cell growth and division. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Ulifloxacin-d8 has also been detected in human urine samples and may have potential as a diagnostic tool for cancer detection. Its effectiveness against various types of tumors makes it a promising candidate for further research and development in the field of oncology.</p>